Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site
about
miR-132/212 cluster inhibits the growth of lung cancer xenografts in nude mice.Salvage treatment with apatinib for advanced non-small-cell lung cancer.Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinomaNanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers.Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties.Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study.
P2860
Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@ast
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@en
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@en-gb
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@nl
type
label
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@ast
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@en
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@en-gb
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@nl
prefLabel
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@ast
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@en
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@en-gb
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@nl
P2093
P2860
P50
P356
P1433
P1476
Development of a highly-potent ...... ng of its VEGFR-2 binding site
@en
P2093
Fahimeh Ghavamipour
Mahmoud Reza Aghamaali
Reza H Sajedi
S Shirin Shahangian
P2860
P304
P356
10.1111/FEBS.12956
P407
P577
2014-10-01T00:00:00Z